Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | OPRD1 | P41143 | 13/20 | 0.74 |
| ▸ | USP2 | O75604 | 2/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.68 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.66 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.59 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.59 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.59 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.59 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.59 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.59 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.59 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.59 |
| ▸ | DRD1 | P21728 | 1/20 | 0.59 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2794662 | 1.00 | MEN1 (1.00) | MEN1KMT2AOPRD1USP2CYP2C9 | |
| SCHEMBL27485345 | 0.98 | MEN1 (0.96) | MEN1KMT2AOPRD1USP2CYP2C9 | |
| Hydrochloric Acid SCHEMBL7006476 | 0.98 | MEN1 (0.96) | MEN1KMT2AOPRD1USP2CYP2C9 | |
| Hydrochloric Acid SCHEMBL11456225 | 0.98 | MEN1 (0.96) | MEN1KMT2AOPRD1USP2CYP2C9 | |
| Piperazine SCHEMBL28229145 | 0.98 | MEN1 (0.96) | MEN1KMT2AOPRD1USP2CYP2C9 | |
| Fluoride SCHEMBL27959930 | 0.98 | MEN1 (0.96) | MEN1KMT2AOPRD1USP2CYP2C9 | |
| SCHEMBL8479321 | 0.92 | MEN1 (0.85) | MEN1KMT2AOPRD1USP2CYP2C9 | |
| Propane SCHEMBL27542064 | 0.91 | MEN1 (0.82) | MEN1KMT2AOPRD1USP2CYP2C9 | |
| Hydrochloric Acid SCHEMBL11455379 | 0.91 | MEN1 (0.82) | MEN1KMT2AOPRD1USP2CYP2C9 | |
| SCHEMBL27167001 | 0.91 | MEN1 (0.82) | MEN1KMT2AOPRD1USP2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1970 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12527755-B2 | Formulations containing acetaminophen and sulfoalkyl ether cyclodextrin | CYDEX PHARMACEUTICALS, INC. (US) | 2026-01-20 | — | — | US | claimed |
| CN-120044159-A | Polygonatum sibiricum medicinal material species identification method based on polygonatum sibiricum characteristic compound and application | 河北北方学院 | 2025-05-27 | — | — | CN | claimed |
| CN-118371269-A | Piperazine ligand modified gold-based catalyst and application thereof in hydrochlorination of acetylene | 鄂尔多斯市瀚博科技有限公司 | 2024-07-23 | — | — | CN | claimed |
| CN-113754597-B | Benzhydryl piperazine compound containing linear olefin and preparation method thereof | 凯美克(上海)医药科技有限公司 | 2024-07-16 | — | — | CN | claimed |
| CN-117925335-A | Semiconductor titanium nitride cleaning solution, and preparation method and application thereof | 浙江奥首材料科技有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-116869983-A | Formulations comprising acetaminophen and sulfoalkyl ether cyclodextrin | 锡德克斯药物公司 | 2023-10-13 | — | — | CN | claimed |
| US-20230270750-A1 | CARBALDEHYDE OXIMES AS BUTYRYLCHOLINESTERASE REACTIVATORS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2023-08-31 | — | — | US | claimed |
| CN-116472267-A | Butyrylcholinesterase reactivating agent | 法兰西国由中央军队卫生服务局代表 | 2023-07-21 | — | — | CN | claimed |
| EP-4188919-A1 | CARBALDEHYDE OXIMES AS BUTYRYLCHOLINESTERASE REACTIVATORS | Etat Français représenté par la Direction Centrale Du Service de Santé des Armées (FR) | 2023-06-07 | — | — | EP | claimed |
| CN-115737648-A | Application of benzhydrylpiperazine compounds in treating echinococcosis | 中国疾病预防控制中心寄生虫病预防控制所(国家热带病研究中心) | 2023-03-07 | — | — | CN | claimed |
| EP-0189679-A1 | Novel crystalline form of 1-benzhydryl-4-allylpiperazine dihydrochloride and method for the production thereof | SO "PHARMACHIM" (BG) | 1986-08-06 | — | — | EP | claimed |
| EP-0062827-B1 | NOVEL BENZAMIDE DERIVATIVES | KYOWA HAKKO KOGYO CO., LTD (JP) | 1986-07-23 | — | — | EP | claimed |
| US-4504481-A | ENZYME INHIBITORS IN LIVER TO REDUCE TOXIC EFFECT OF DRUGS | RICHTER GEDEON VEGYESZETI GYAR RT. (HU) | 1985-03-12 | — | — | US | claimed |
| EP-0006227-B1 | ANTITHROMBOTIC PHARMACEUTICAL PREPARATION CONTAINING 2,2'-DITHIOBIS BENZAMIDE DERIVATIVES AND NEW 2,2'-DITHIOBIS BENZAMIDE DERIVATIVES | KYOWA HAKKO KOGYO CO., LTD (JP) | 1984-12-27 | — | — | EP | claimed |
| EP-0115203-A1 | Benzhydrylpiperazine derivatives, process for their preparation and pharmaceutical compositions containing them | Richter Gedeon Vegyészeti Gyár R.T. (HU) | 1984-08-08 | — | — | EP | claimed |
| EP-0058146-B1 | 2-(4-(DIPHENYLMETHYL)-1-PIPERAZINYL)-ACETIC ACIDS AND THEIR AMIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS | U C B, S.A. (BE) | 1984-06-27 | — | — | EP | claimed |
| US-4448776-A | Method of using certain substituted aliphatic secondary amines or their salts for easing breathing | BUCHER KARL (CH) | 1984-05-15 | — | — | US | claimed |
| EP-0097340-A2 | Piperazine derivatives, a process for preparing them and pharmaceutical compositions | FERRER INTERNACIONAL, S.A. (ES) | 1984-01-04 | — | — | EP | claimed |
| EP-0062827-A2 | Novel benzamide derivatives | KYOWA HAKKO KOGYO CO., LTD (JP) | 1982-10-20 | — | — | EP | claimed |
| EP-0058146-A1 | 2-(4-(Diphenylmethyl)-1-piperazinyl)-acetic acids and their amides, process for their preparation and pharmaceutical compositions | U C B, S.A. (BE) | 1982-08-18 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230270750-A1 | CARBALDEHYDE OXIMES AS BUTYRYLCHOLINESTERASE REACTIVATORS | BCHE, ACHE, CHAT | MEN1 3307/4885KMT2A 1473/4885OPRD1 887/4885 |
| US-12527755-B2 | Formulations containing acetaminophen and sulfoalkyl ether cyclodextrin | TPMT, GSTP1, ALB | MEN1 4265/4885KMT2A 4604/4885OPRD1 38/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.